NDC 54868-1259-3 - COUMADIN

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
54868-1259
Requested NDC
54868-1259-3
Package NDCs from labels
54868-1259-0, 54868-1259-1, 54868-1259-5, 54868-1259-6, 54868-1259-7, 54868-1259-3
Manufacturer
Physicians Total Care, Inc.
Effective date
2012-11-15
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
COUMADIN - Physicians Total Care, Inc.Physicians Total Care, Inc.2012-11-15HUMAN PRESCRIPTION DRUG LABEL
National Council for Prescription Drug Programs indexing - billing unitNational Council for Prescription Drug Programs2012-07-24Indexing - Billing Unit

FDA-Initiated Inactive NDC Indexing#

NDC, Related label table
NDCRelated label
54868-1259-0These highlights do not include all the information needed to use COUMADIN safely and effectively. See full prescribing information for COUMADIN. COUMADIN (warfarin sodium) tablets, for oral use COUMADIN (warfarin sodium) for injection, for intravenous use Initial U.S. Approval: 1954
54868-1259-1These highlights do not include all the information needed to use COUMADIN safely and effectively. See full prescribing information for COUMADIN. COUMADIN (warfarin sodium) tablets, for oral use COUMADIN (warfarin sodium) for injection, for intravenous use Initial U.S. Approval: 1954
54868-1259-5These highlights do not include all the information needed to use COUMADIN safely and effectively. See full prescribing information for COUMADIN. COUMADIN (warfarin sodium) tablets, for oral use COUMADIN (warfarin sodium) for injection, for intravenous use Initial U.S. Approval: 1954
54868-1259-6These highlights do not include all the information needed to use COUMADIN safely and effectively. See full prescribing information for COUMADIN. COUMADIN (warfarin sodium) tablets, for oral use COUMADIN (warfarin sodium) for injection, for intravenous use Initial U.S. Approval: 1954
54868-1259-7These highlights do not include all the information needed to use COUMADIN safely and effectively. See full prescribing information for COUMADIN. COUMADIN (warfarin sodium) tablets, for oral use COUMADIN (warfarin sodium) for injection, for intravenous use Initial U.S. Approval: 1954

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
54868-1259-0COUMADIN20 in 1 BOTTLETABLET204
54868-1259-1COUMADIN30 in 1 BOTTLETABLET304
54868-1259-5COUMADIN90 in 1 BOTTLETABLET904
54868-1259-6COUMADIN10 in 1 BOTTLETABLET104
54868-1259-7COUMADIN75 in 1 BOTTLETABLET754

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
54868-1259COUMADIN (WARFARIN SODIUM) TABLET [PHYSICIANS TOTAL CARE, INC.]45 package rows20130315_91fa852c-b43d-4a55-983b-74aa6827125d.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
54868-1259-0EA - Each54868-12598b5b26ca-e3c9-4a53-9f83-baf84dbee03712012-07-24
54868-1259-1EA - Each54868-125969dfcbef-4e41-4753-bc88-6df57a24f88612012-07-24
54868-1259-2EA - Each54868-1259e8125368-1d7d-42b3-9c7a-ca642e23156d12012-07-24
54868-1259-3EA - Each54868-1259bc57a6ef-4bf3-47ba-aead-6e2a9007b56512012-07-24
54868-1259-5EA - Each54868-1259507cc9a0-1715-4457-aecc-ffd1fb17b37f12012-07-24
54868-1259-6EA - Each54868-1259ccd1013f-58e0-4490-b676-db86f1fe0ac012012-07-24
54868-1259-7EA - Each54868-125961711844-8eb9-4417-afb5-4783ad02466a12012-07-24

DailyMed Socrata Ingredients#

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 3 of 12 · 230 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Varibar PuddingBARIUM SULFATEE-Z-EM Canada Inc553285e2-d0e9-8b7b-4766-a0a6b9496f872026-05-15Warnings, Adverse reactionsExact identifier
unii: 25BB7EKE2E
Varibar NectarBARIUM SULFATEE-Z-EM Canada Inc5e7045f7-b771-d8af-ce30-be95b2597c102026-05-15Warnings, Adverse reactionsExact identifier
unii: 25BB7EKE2E
ENTERO Vu 24%BARIUM SULFATEE-Z-EM Canada Inc83a06a8e-93db-a59b-933c-5882127bce7c2026-05-15Warnings, Adverse reactionsExact identifier
unii: 25BB7EKE2E
Kesin MAG-AL PlusALUMINUM AND MAGNESIUM HYDROXIDE W/SIMETHICONE SUSPENSIONKesin Pharma Corporation436b622a-f028-df98-e063-6394a90a3eaa2026-05-08WarningsExact identifier
unii: 5QB0T2IUN0
Kesin MAG-AL Plus XSALUMINUM AND MAGNESIUM HYDROXIDE W/SIMETHICONE SUSPENSIONKesin Pharma Corporation436b89f7-e417-0df2-e063-6394a90a96df2026-05-08WarningsExact identifier
unii: 5QB0T2IUN0
Kesin MAG-ALALUMINUM AND MAGNESIUM HYDROXIDE SUSPENSIONKesin Pharma Corporation42df2198-14dc-da1c-e063-6394a90a1ae62026-05-08WarningsExact identifier
unii: 5QB0T2IUN0
GERI-LANTA ANTACID ANTIGASALUMINUM HYDROXIDE, MAGNESIUM HYDROXIDE, DIMETHICONEPreferred Pharmaceuticals Inc.27848ae0-3b2f-4bfe-8856-4b8de419091e2026-05-06WarningsExact identifier
unii: 5QB0T2IUN0
REGULAR STRENGTH ANTACIDALUMINUM HYDROXIDE, MAGNESIUM HYDROXIDE, DIMETHICONEPreferred Pharmaceuticals Inc.ad3e7ebe-f2a9-4305-b370-59785f5396c82026-05-06WarningsExact identifier
unii: 5QB0T2IUN0
Warfarin SodiumWARFARIN SODIUMREMEDYREPACK INC.6b227c9e-02e9-4ec9-8b11-3ab6fe5093e52026-04-27Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 855312
unii: 6153CWM0CL
Warfarin SodiumWARFARIN SODIUMREMEDYREPACK INC.72d3ea20-27e4-4368-a666-a9b76530dbb92026-04-27Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 855332
unii: 6153CWM0CL
Warfarin SodiumWARFARIN SODIUMREMEDYREPACK INC.61ab23a7-bc67-4777-854a-bf43c788a69a2026-04-27Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 855344
unii: 6153CWM0CL
Warfarin SodiumWARFARIN SODIUMREMEDYREPACK INC.7b3b6f89-1feb-4939-a95b-7ad0707f4d762026-04-27Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 855296
unii: 6153CWM0CL
Warfarin SodiumWARFARIN SODIUMREMEDYREPACK INC.73b8e5ab-86f8-44f8-b290-346acb81c9ae2026-04-27Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 855288
unii: 6153CWM0CL
E-Z-PaqueBARIUM SULFATEE-Z-EM Canada Inc7225868a-4037-c96a-44e3-3326d36cbedc2026-04-15Warnings, Adverse reactionsExact identifier
unii: 25BB7EKE2E
AntacidALUMINUM HYDROXIDE, MAGNESIUM HYDROXIDE, SIMETHICONERugby Laboratoriesbd58baac-5790-455a-9c77-2366809925792026-04-15WarningsExact identifier
unii: 5QB0T2IUN0
E-Z-PaqueBARIUM SULFATEE-Z-EM Canada Inc2ecea1ab-66c8-4eb0-8503-6d6b41b513282026-04-15Warnings, Adverse reactionsExact identifier
unii: 25BB7EKE2E
Varibar Thin LiquidBARIUM SULFATEE-Z-EM Canada Inc59493c83-3941-cc84-cc37-a8696ae428732026-04-15Warnings, Adverse reactionsExact identifier
unii: 25BB7EKE2E
Readi-Cat 2 Berry SmoothieBARIUM SULFATEE-Z-EM Canada Incd2d293d5-dcc9-0d3f-58ed-686ef0132d7c2026-04-15Warnings, Adverse reactionsExact identifier
unii: 25BB7EKE2E
E-Z-HDBARIUM SULFATEE-Z-EM Canada Inca4330804-7179-472a-91cb-84bbd5079bb82026-04-15Warnings, Adverse reactionsExact identifier
unii: 25BB7EKE2E
Tagitol VBARIUM SULFATEE-Z-EM Canada Inc30c68756-c7db-bf50-9cd5-ef4b0c7ab1d02026-04-15Warnings, Adverse reactionsExact identifier
unii: 25BB7EKE2E

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.